Inogen | INGN - Des Atouts





Des Atouts Changement Date
Abbott USD 86.71B 2.53B 2025-12
Accuray USD 456.82M 13.42M 2025-09
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 884.8M 27.13M 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Chart Industries USD 9.81B 16.6M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Globus Medical USD 5.3B 207.12M 2025-12
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.19B 161.1M 2025-12
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.48B 139M 2025-12
Orthofix International USD 850.65M 18.04M 2025-12
Philips EUR 26.94B 605M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Steris USD 10.59B 180.7M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
X T L Biopharmaceuticals USD 714K 7.84M 2025-06
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12